Chard Daniel R
Chairman & CEO
Chard Daniel R has filed 1 SEC Form 4 filing (6 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 27, 2026.
On the most recent filing, Chard Daniel R is listed as Chairman & CEO at MEDIFAST INC. Inside the rolling window, Chard Daniel R reported 1 open-market purchase totaling $179K in MED and no open-market sales.
Companies traded
Other insiders at MED
Insider Buying
$179K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Chard Daniel R made?
Chard Daniel R has filed 1 SEC Form 4 filing (6 transaction rows) across 1 company since 2026.
Which companies does Chard Daniel R trade?
Chard Daniel R has filed SEC Form 4 disclosures for 1 company, including MED.
When was Chard Daniel R's most recent SEC Form 4 filing?
Chard Daniel R's most recent SEC Form 4 filing on Tracefour is dated Mar 27, 2026.
What is Chard Daniel R's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Chard Daniel R is listed as Chairman & CEO.
What is Chard Daniel R's total buy and sell value in the current window?
Inside the rolling retention window, Chard Daniel R bought $179K and sold $0 based on SEC Form 4 filings.
What was Chard Daniel R's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 17,678 MED shares on 2026-03-20, worth $179K, per SEC Form 4 filings.